Malignancies of lympho-hematopoietic lineage and alloreactive natural killer (NK) cell killing.*
| Susceptible . | Resistant . |
|---|---|
| *Results of multiple 51Cr-release cytotoxicity experiments for each malignancy using alloreactive NK clones as effectors. | |
| T-cell phenotype acute lymphoblastic leukemia | Common phenotype acute lymphoblastic leukemia |
| Acute myeloblastic leukemias | |
| Chronic myelogenous leukemia | |
| Chronic lymphocytic leukemia | |
| Non-Hodgkin’s lymphomas | |
| Multiple myeloma | |
| Susceptible . | Resistant . |
|---|---|
| *Results of multiple 51Cr-release cytotoxicity experiments for each malignancy using alloreactive NK clones as effectors. | |
| T-cell phenotype acute lymphoblastic leukemia | Common phenotype acute lymphoblastic leukemia |
| Acute myeloblastic leukemias | |
| Chronic myelogenous leukemia | |
| Chronic lymphocytic leukemia | |
| Non-Hodgkin’s lymphomas | |
| Multiple myeloma | |